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Ultraviolet B radiation not only inflicts tumor-initiat-
ing DNA damage, but also impairs T cell-mediated
immunity relevant to survival of the initiated cells. We
have reported, however, that ultraviolet A radiation,
in contrast, is immunologically innocuous in hairless
mice and opossums, but renders the animals resistant
to the immunosuppression by ultraviolet B, or its
mediator cis-urocanic acid. Ultraviolet B irradiation
of skin causes abundant release of numerous cytokines
(interleukin-1, interleukin-6, interleukin-10, tumor
necrosis factor-a); notably interleukin-12 and inter-
feron-g do not appear to be upregulated. A recent
report has indicated that interleukin-12 protects from
photoimmunosuppression in mice, but it remains
unclear whether interleukin-12 acts directly or via
interferon-g, which it is known to stimulate. Here we
investigate the possible role of interferon-g in UVA
photoimmunoprotection, using interferon-g gene
knockout mice in comparison with control C57/BL6
mice, and the systemic contact hypersensitivity reac-
tion (induced by sensitization through a nonirradiated
skin site) to measure immunity. interferon-g–/– mice
Ultraviolet (UV) irradiation causes the cutaneouscytokine environment to change in such a way thatthere is local and systemic impairment of antigenpresentation, and an altered T lymphocyte responseskewed towards predominantly T helper-2 cell
(Th2) activity at the expense of Th1 activity (Noonan et al, 1988;
Ullrich, 1996). The Th2-derived cytokine interleukin (IL)-10 in
particular appears to play a major part in photoimmunosuppression
and is released by UVB (280–320 nm)-irradiated murine ker-
atinocytes; this cytokine was shown both to inhibit Langerhans cell
presentation of tumor-associated antigens (Beissert et al, 1995a), and
to suppress, systemically, delayed type and contact hypersensitivity
(CHS) in mice (Rivas and Ullrich, 1992).
In contrast, the Th1 cytokine IL-12 was found to block the
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raised normal contact hypersensitivity responses, and
were unaffected, as were C57BL control mice, by
ultraviolet A exposure. In response to ultraviolet B
irradiation or topical cis-urocanic acid treatment, con-
trol mice became immunosuppressed by 69% and
27%, respectively, and interferon-g–/– mice by 79%
and 27%. When ultraviolet B exposure or cis-urocanic
acid was followed by ultraviolet A irradiation, however,
contact hypersensitivity was totally restored in control
mice, but remained suppressed by 55% and 25%,
respectively, in interferon-g–/– mice. Injection of
recombinant interferon-g in the interferon-g–/– mice
restored the ultraviolet A protective effect against
cis-urocanic acid-induced immunosuppression. These
observations suggest that interferon-g plays a part in
ultraviolet A immunoprotection from the suppressive
effect of ultraviolet B radiation and, and that the
mechanism appears to be via antagonism by this
cytokine of the cis-urocanic acid immunosuppressive
action. Key words: contact hypersensitivity/cytokine/gene
knockout mouse/urocanic acid. J Invest Dermatol 112:945–
950, 1999
secretion of IL-10 by UVB-irradiated keratinocytes in vitro.1 IL-12
has dominant effects on promoting Th1 development (Manetti
et al, 1993), has anti-tumor activity in mice (Brunda et al, 1993),
and appears to act by stimulating interferon (IFN)-γ upregulation
(Trinchieri, 1993). IFN-γ itself has a positive feedback effect
by enhancing production of IL-12, blocks endogenous IL-10
production by macrophages (Chomarat et al, 1993), is itself down-
regulated by IL-10 (Kondo et al, 1994), but upregulated in mice
by anti-IL-10 (Arai et al, 1995). Whereas IFN-γ has been shown
to be suppressed by UVB irradiation (Khan et al, 1993; Teunissen
et al, 1993; Simon et al, 1994) and to be critically important in the
accompanying failure of tumor rejection (Gensler et al, 1995),
IL-12 has also been shown to be reduced after UVB irradiation
(Kremer et al, 1996), and to have the capacity to inhibit photo-
immunosuppression in mice (Muller et al, 1995; Schmitt et al,
1995; Schwarz et al, 1996). There is thus a complex regulatory
interplay in determining the cutaneous cytokine environment and
the predominance of either immunopotentiating (IL-12, IFN-γ) or
immunosuppressive (IL-10) responses following UVB irradiation.
The carcinogenic and immunosuppressive effects of UVB radi-
ation appear to be related. Definitive evidence in mice has recently
shown that both the presentation of tumor-associated antigens for
the induction of protective tumor immunity, and the elicitation of
delayed type hypersensitivity against the antigenic tumor were
suppressed by UV irradiation (Beissert et al, 1995b). For this reason,
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better understanding of the photoimmunosuppressed state should
identify possible pathways of intervention and control of this UV
radiation-induced defect which seems critical to photocarcino-
genesis.
We have observed, in both the marsupial Monodelphis domestica
(Reeve and Ley, 1997) and the Skh:HR hairless mouse (Reeve
et al, 1998), that suberythemal exposure to stringently filtered UVA
radiation consistently provided protection from the suppression of
CHS induced by UVB radiation or by topical exogenous cis-
urocanic acid, a natural epidermal UVB-photoproduct and putative
initiator of photoimmunosuppression (Norval et al, 1995). The
mechanism(s) in the two species of experimental animal is entirely
unknown. As the UVA irradiation remained immunoprotective
whether administered after the UVB (or cis-urocanic acid), or up
to 24 h before, however, we have suggested that UVA must induce
the formation of a persistent photoproduct(s), as yet unidentified.
We hypothesize that this product might be either IL-12, a cytokine
found to prevent photoimmunosuppression in other studies, or
IFN-γ which may be upregulated by IL-12. Mice bearing a targeted
disruption of the IFN-γ gene (IFN-γ–/–) have therefore been
exposed to UVA radiation in combination with UVB or cis-
urocanic acid treatment, and the effect on the murine immune
status has been assayed by the systemic CHS reaction, which is a
classic Th1 cell-dependent response.
MATERIALS AND METHODS
Mice A breeding nucleus of mice bearing a targeted disruption of the
IFN-γ gene on the C57BL/6 genetic background was kindly provided by
Professor N. Hunt, Department of Pathology, University of Sydney. The
mice for the study were bred and maintained under conventional housing
conditions in wire-topped plastic microisolation cages in the Department
of Veterinary Anatomy and Pathology’s small animal facility, University of
Sydney. Control C57BL/6 mice were also bred under conventional housing
conditions in that department, and both strains of mice were maintained
under gold lighting, which does not emit any UVB radiation (GEC F40GO
tubes), at an ambient temperature of 21–24°C. They were bedded on
vermiculite (Boral, Camellia, NSW) and fed stock mouse pellets and water
ad libitum. At 24 h before irradiation or sensitization, fur was removed
from the dorsum or abdomen, respectively, with Oster clippers (Sunbeam
Appliances, Campsie, NSW). For inclusion in the study, mature mice
predominantly in the resting stage of hair growth (pink skin) were selected,
both males and females being used at ages 18–29 wk, in matched groups
differing in age by less than 4 wk.
Some IFN-γ–/– mice (groups of four to six) were reconstituted
with this cytokine by injecting recombinant IFN-γ (r-IFN-γ) (gift from
K. Beagley, Division of Immunology, Newcastle University Medical
School, NSW) intraperitoneally immediately following and again at 24 h
following UVA irradiation, at doses of 32–3200 U per 0.1 ml in normal
saline. The injections did not cause any gross effects.
UV irradiation The radiation sources were made up of 120 cm
fluorescent tubes held in a reflective batten 19 cm above the irradiation
table surface. Irradiance was measured using an International Light IL1500
radiometer with two detectors (SEE 015/UVA and SEE 240/UVB) which
had been calibrated to the relevant spectral irradiances of the sources
(F. Wilkinson, CSIRO National Standards Laboratory, Bradfield Park,
NSW). The UVB radiation was provided by a single unfiltered UVB tube
(Oliphant FL40SE) emitting 2.5 3 10–4 W per cm2 UVA and 4.1 3 10–4 W
per cm2 UVB. The UVA source was a planar bank of seven UVA tubes
(Hitachi F40/T 10BL) filtered through a sheet of 6 mm window glass,
providing 2.7 3 10–3 W per cm2 UVA and 2.3 3 10–8 W per cm2 UVB.
The transmission properties of the 6 mm window glass filter, which was
selected from several 6 mm window glass samples for its superior UVA/
UVB transmission ratio, were measured in a Perkin-Elmer UV-VIS
spectrophotometer and the filter was found to be opaque to wavelengths
less than 320 nm.
Mice previously clipped of dorsal fur were exposed on the dorsum,
unrestrained in their cages with the wire tops removed, to a single dose
of UVB radiation (4.35 kJ per m2 UVA, 7.08 kJ per m2 UVB) approximately
equivalent to three times the minimal erythemal dose (MED), previously
determined by its edema component from a series of increasing exposures
by measuring the mid-dorsal skinfold thickness with a spring micrometer
(Mercer, St. Albans, U.K.) at 24 h postirradiation. When required, UVA
irradiation followed immediately after the UVB exposure.
UVA was administered as a single 4 h exposure (387.4 kJ per m2 UVA,
0.334 3 10–3 kJ per m2 UVB), approximately equal to the UVA content
of 5 MED of sunlight (Reeve et al, 1998). This UVA exposure, therefore,
would be reasonably attainable by sunscreen-protected humans in a day of
recreational sunlight exposure. The UVB contamination of the UVA
radiation doses, measured radiometrically, was negligible, being approxi-
mately equal to 0.0085% of the UVB content of 1 MED of sunlight.
Temperature was controlled with an electric fan, and the boxes of mice
were gently shaken regularly to prevent shielding by sleeping cage mates,
especially during the longer exposure times with UVA.
Cis-urocanic acid lotion Trans-urocanic acid (Sigma, St. Louis, MO)
was photoisomerized in dimethyl sulfoxide solution to a mixture of 52%
trans-isomer and 48% cis-isomer as previously described (Reeve et al, 1993).
Lotions containing 0.2% (wt/vol) of trans-urocanic acid or UV-irradiated
urocanic acid, referred to here as ‘‘cis-urocanic acid’’, were prepared in an
innocuous cosmetic oil-in-water lotion, with a final concentration of 5%
(vol/vol) dimethyl sulfoxide, and were stored in the dark at 4°C. The base
lotion was identical in composition, without added urocanic acid (Reeve
et al, 1993). Aliquots of 0.1 ml (200 µg urocanic acid) were spread evenly
over the mouse dorsum by pipette and allowed to be absorbed for 30 min.
Control mice received the base lotion only. The lotion applications were
repeated after 4 h, with UVA exposure following the second topical
application after 30 min
Induction of CHS CHS was induced in groups of five to six mice, on
the eighth and ninth days after the irradiation treatments as previously
described (Reeve et al, 1994); one of either of two contact sensitizers,
0.1 ml 2% (wt/vol) oxazolone (Sigma) in ethanol, or 0.05 ml 0.15% (vol/
vol) 2,4-dinitrofluorobenzene (DNFB; Sigma) in acetone, was used,
dictated by the temporary unavailability of fresh supplies of oxazolone
during the course of the studies. Sensitization was always on the shaved
unirradiated abdominal skin for induction of systemic CHS. The mice
were challenged 7 d after sensitization with 5 µl 2% oxazolone/ethanol or
0.15% DNFB/acetone, respectively, applied to each surface of both pinnae.
Ear swelling was calculated at the peak of the response, usually at 18–20 h,
by the difference in the prechallenge and postchallenge ear thicknesses
measured with the spring micrometer (Mercer). The experiments were
performed at least twice, with data presented here from single experiments
with the comparative treatments performed simultaneously; this was because
baseline CHS responses vary a little from study to study. Statistical
significance of differences between treatments was assessed by t test.
Assay of epidermal urocanic acid isomers The shaved dorsal skins
from groups of three unirradiated and three UVA-irradiated mice of
each strain (C57BL control and IFN-γ–/–) were excised immediately
postirradiation, chilled on ice, heat shocked for 45 s at 55°C, chilled on
ice, and the epidermis removed by gentle scraping with a scalpel blade.
Urocanic acid was extracted in NH4OH/ethanol as previously described
and analyzed by thin-layer chromatography (Reeve et al, 1993).
RESULTS
Erythema/edema responses The average increases in 24 h
mid-dorsal skinfold thickness in groups of six or eight mice are
shown in Fig 1. It is evident that this UVA radiation dose resulted
in a slight but not statistically significant decrease in skinfold
thickness, probably of no biologic relevance, in both the C57BL
and the IFN-γ–/– mice. The UVB exposure caused a moderate
increase in skinfold thickness in both strains, and although the
average increase was apparently less in the IFN-γ–/– mice, this
difference was not statistically significant (p . 0.1). A similar
increase in skinfold thickness occurred following the exposure of
C57BL mice to UVB 1 UVA, indicating that UVA had no
significant effect on the normal UVB erythema as previously
observed in Skh:HR mice (Reeve et al, 1998). IFN-γ–/– mice,
however, failed to develop a significant erythema (p , 0.01) in
comparison, suggesting that IFN-γ may be involved in part of the
normal expression of the erythema reaction.
Epidermal cis-urocanic acid formation Total urocanic acid
extracted from the epidermis was between 7.8 and 10.6 µg per
cm2 skin area (Table I). There was no significant difference
between C57BL and IFN-γ–/– mice. Low levels of the cis isomer
were detected in unirradiated skin, 0.31 and 1.2 µg per cm2 in
C57BL and IFN-γ–/–, respectively, but these were not significantly
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Figure 1. Erythema/edema responses postirradiation. Average
increase in mid-dorsal skinfold thickness 6 SEM at 24 h following exposure
to UVA, UVB, or UVB 1 UVA radiation, in C57BL (n 5 8) and IFN-
γ–/– (n 5 6) mice.
Table I. Average total and cis-urocanic (UCA) acid
concentrations (KSD) in dorsal epidermal extracts of
untreated and UVA-irradiated mice, expressed as
mg per cm2 of skin area. n J 3
Total [UCA] [cis-UCA]
Mouse µg per cm2 µg per cm2 % cis-UCA
C57BL 10.4 6 1.1 0.31 6 0.43 3.0
C57BL 1 UVA 10.6 6 1.0 3.1 6 0.8 29.2
IFN-γ–/– 8.4 6 3.5 1.2 6 0.9 14.3
IFN-γ–/– 1 UVA 7.8 6 1.0 2.5 6 0.6 32.1
different between the strains, and probably represent adventitious
photoisomerization during the extraction procedure. Following
UVA exposure, the cis-urocanic acid content increased to 3.1 and
2.5 µg per cm2, respectively, accounting for 29% and 32% of the
total epidermal urocanic acid. Again there was no significant
difference between the two mouse strains, indicating that the
availability of cis-urocanic acid was not a factor in the differing
immune responses of these mice.
Effect of UVA radiation on UVB-suppressed CHS
C57BL mice Experimental photoimmunoprotection by UVA radi-
ation had previously been observed only in Skh:HR mice and the
marsupial Monodelphis domestica (Reeve and Ley, 1997; Reeve et al,
1998). Here the finding has been confirmed also in the conventional
haired C57BL mouse (Fig 2A). Consistent with the previous
observations, UVA irradiation was immunologically inert under
these conditions (no significant difference from unirradiated mice).
Exposure to UVB radiation suppressed CHS to DNFB by 69%,
but this was completely prevented by the subsequent exposure to
UVA, restoring the response to normal.
IFN-γ–/– mice The capacity of this gene knockout mouse to
express CHS was unknown, but as CHS is a classical Th1-mediated
reaction, it seemed possible that IFN-γ dependence would be
revealed. We found, however, that this mouse produced normal
ear swelling reactions after challenge with DNFB, differing only
slightly from the C57BL mouse (Figs 2 and 3).
As in the control C57BL mice, CHS in the IFN-γ–/– mice was
unaffected by UVA irradiation (Fig 2B). When IFN-γ–/– mice
Figure 2. Effect of UVA, UVB on CHS reaction. CHS to DNFB,
measured as average ear swelling 6 SEM in (A) C57BL and (B) IFN-γ–/–
mice (n 5 5 or 6) following exposure to UVA, UVB, or UVB 1 UVA
radiation. I/S, immunosuppression; NSD, no significant difference.
were exposed to UVB radiation, 79% suppression of CHS to
DNFB was detected. Subsequent UVA irradiation appeared to
reduce slightly the degree of UVB suppression to 55%, but this
reduction was not statistically significant and the mice remained
markedly immunosuppressed. Thus in contrast to the control
C57BL mice, UVA had no significant ameliorating effect on UVB-
induced suppression of CHS in the IFN-γ–/– mice.
Effect of UVA irradiation on cis-urocanic acid-suppressed
CHS
C57BL mice The exposure of C57BL mice to UVA radiation
through the base lotion did not significantly affect CHS to oxazolone
compared with the unirradiated mice (Fig 3A), nor did topical
application of trans-urocanic acid lotion have an effect. Application
of cis-urocanic acid lotion suppressed CHS by 27%. When the cis-
urocanic acid treatment was followed by UVA irradiation, however,
almost total restoration of the CHS response (4% suppression) was
found. Trans-urocanic acid followed by UVA had no effect on the
normal CHS reaction.
IFN-γ–/– mice As observed in control C57BL mice, neither UVA
irradiation through the base lotion, nor application of trans-urocanic
acid lotion, nor the combination of trans-urocanic acid with
subsequent UVA irradiation, had any significant effect on CHS to
oxazolone (Fig 3B) compared with unirradiated IFN-γ–/– mice.
Topical application of cis-urocanic acid lotion suppressed CHS in
these mice by 27%. Subsequent UVA exposure, unlike the response
in control C57BL mice, did not significantly alter this suppressed
CHS (25% suppression). Thus in contrast with the control C57BL
mice, UVA did not reduce the degree of cis-urocanic acid-induced
suppression of CHS in the IFN-γ–/– mice.
948 REEVE ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 3. Effect of UVA, cis-urocanid acid, on CHS reaction. CHS
to oxazolone, measured as average ear swelling 6 SEM in (A) C57BL and
(B) IFN-γ–/– mice (n 5 5 or 6) following UVA irradiation and cis-
urocanic acid or trans-urocanic acid (cis-UCA) treatments, compared with
base lotion applications.
Reconstitution of IFN-g–/– mice with r-IFN-g
Reconstituted mice were treated topically with cis-urocanic acid,
with and without subsequent UVA irradiation. There were no
guidelines for IFN-γ dosage in the mouse; therefore, serial dilutions
of r-IFN-γ were tested. It was found that there was a [r-IFN-γ]-
dependent abrogation of the capacity of cis-urocanic acid to suppress
CHS (Fig 4A) in the IFN-γ–/– mouse, in comparison with the
response following UVA irradiation alone, and that the highest
dose of r-IFN-γ, 32,000 U per mouse, actually markedly potentiated
CHS even in the presence of cis-urocanic acid. Although this
response indicated a nonphysiologic overdose of the cytokine, it
supported the part played by IFN-γ in antagonizing photoimmuno-
suppression. At the lower doses which appeared to be more
accurately reconstitutive, so that cis-urocanic acid immunosuppres-
sion was apparent, photoimmunoprotection against cis-urocanic
acid could be seen to have been restored (Fig 4B), strengthening
the evidence for the involvement of IFN-γ as the critical factor in
UVA immunoprotection.
DISCUSSION
This study has demonstrated photoimmunoprotection by UVA
radiation in the C57BL mouse, consistent with our previous reports
in the Skh:HR hairless mouse, and in Monodelphis domestica. Like
the earlier studies, UVA exposure itself was immunologically
innocuous, produced abundant photoisomerization to cis-urocanic
acid in the epidermis, but endowed the C57BL mouse with
Figure 4. Effect of r-IFN-g injection in IFN-g–/– mice. (A) Percentage
suppression 6 SD of CHS by cis-urocanic acid in IFN-γ–/– (n 5 4 or 6)
mice injected with different doses of r-IFN-γ and (B) the CHS responses
to oxazolone of the injected mice following UVA irradiation and cis-
urocanic acid treatment with and without UVA irradiation, measured as
average ear swelling 6 SEM.
resistance to the immunosuppressive effects of both UVB radiation,
and exogenously applied cis-urocanic acid.
We observed that the effects of exogenous cis-urocanic acid
mirrored those of UVB radiation, and cis-urocanic acid appeared
to fulfill the role of photoimmunosuppressive mediator consistently
under our study conditions. The resolution of the mechanism by
which cis-urocanic acid interacts with the regulatory cytokines
would seem to provide important information identifying essential
reactions relevant to photoimmunosuppression. Unfortunately,
these remain unclear. A recent study in mice shows that cis-urocanic
acid-dependent establishment of hapten-specific tolerance could
be antagonized by intraperitoneally injected anti-IL-10 antibody
(Niizeki and Streilein, 1997). On the other hand, cis-urocanic acid
did not induce cytokine changes in human keratinocytes (Redondo
et al, 1996), nor alter expression of costimulatory antigens in human
monocytes when this was induced by IFN-γ (Laihia et al, 1996),
and in suction blister fluid from human skin, there was no cis-
urocanic acid-dependence of tumor necrosis factor-α production
under conditions where this cytokine was enhanced by UVB and
depressed by UVA-1 irradiation (Skov et al, 1998). Future studies
are hoped to clarify how cis-urocanic acid interacts with or modifies
the relevant cytokines in the skin or systemically.
Availability of the IFN-γ–/– mouse enabled us to examine the
role of this Th1 cytokine in the UVB impairment of CHS, a
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normal T cell-mediated response, and in the modification of
this response by UVA exposure, alone or combined with UVB
irradiation. The observation of a normal CHS response in the
deficient mouse, a reaction considered as a prototype marker of
Th1 activity, was unexpected. This was consistent, however, with
the reported observation of normal CHS reactivity also in IFN-γ
receptor deficient mice (Saulnier et al, 1995), and suggests that
IFN-γ acts in concert with other Th1 cytokines for normal CHS
expression and that redundancy must exist between these mediators.
The similar degrees of impairment of CHS induced in each mouse
strain by either UVB or cis-urocanic acid is also consistent with a
redundancy of regulatory mediators of the photoimmuno-
suppressed state.
It seemed, however, that IFN-γ was necessary for the production
of a normal erythema under our study conditions. Saulnier et al
(1995) found that the edema in CHS was independent of IFN-γ,
although other components of the inflammatory CHS reaction
such as microabscess formation and cellular infiltrate were reported
to be IFN-γ dependent. Perhaps the edema component of the
UVB-erythema or UVB 1 UVA-erythema inflammatory reaction,
by which the skinfold thickness is largely determined, depends to
a greater degree on the local Th1 cytokines than the systemic CHS
edema reaction. It is interesting that IL-10 has been described as a
natural suppressant of cutaneous inflammatory responses, e.g.,
induced by croton oil, in mice (Berg et al, 1995). A local
overexpression of anti-inflammatory IL-10 and other Th2 cyto-
kines, caused by the deficiency of IFN-γ, may explain the inability
of the IFN-γ–/– mouse to develop a UV-erythema. Alternatively,
as IFN-γ appears to enhance histamine release from mast cells
(Yanagida et al, 1996), deficiency of IFN-γ may reduce the histamine
contribution to erythema inflammation. Our data also indicate
reduction of the erythema response to UVA 1 UVB compared
with UVB in the absence of IFN-γ, which suggests that there is
a normal contribution to erythema of other IFN-γ-dependent
inflammatory mediators which are preferentially activated by UVA
radiation, perhaps other Th1 cytokines. Their identity, however,
is not clear at this time.
Several recent studies now provide evidence that IL-12 is able
to counteract UVB-induced immunosuppression in mice, and to
reduce suppressor T cell formation and activity (Schmitt et al, 1995;
Schwarz et al, 1996). As it was found that IL-12 enhanced Th1
cell development that had been blocked by anti-IFN-γ monoclonal
antibody, if activity was assayed by an antigen presentation-
independent assay, but failed to enhance anti-IFN-γ-blocked Th1
development if assayed by an antigen presentation-dependent assay
(Seder et al, 1993), the question of the involvement of IFN-γ in
the mode of action of IL-12 has been difficult to define. It was
suggested that the balance of IFN-γ and IL-10-producing T cells
determined CHS responses in BALB/C mice (Xu et al, 1996).
Kremer et al (1996) observed that the depletion of IFN-γ from
monocytes by UVB irradiation could be restored by r-IL-12, and
a preliminary report has provided evidence in mice that anti-IFN-
γ monoclonal antibody had no effect on the ability of IL-12 to
overcome UVB immunosuppression,1 pinpointing IL-12, not IFN-
γ as the immunoprotective cytokine. In spite of this, our study
suggests that the critical Th1 cytokine acting in photo-
immunoprotection is IFN-γ and that the mechanism of UVA
prevention of photoimmunosuppression in the mouse is dependent
on IFN-γ. Restoration of UVA photoimmunoprotection by the
injection of r-IFN-γ provides additive evidence for the role of
this cytokine.
It has been of interest that atopic dermatitis in humans, which
is characterized by overexpression of IL-10 (Ohmen et al, 1995)
appears to be responsive to therapy by high-dose UVA-1 irradiation
(Krutmann et al, 1992) and also by systemic IFN-γ therapy (Musial
et al, 1995), thus apparently aligning UVA exposure with the Th1
cytokines in the normalization of the imbalanced cytokine array of
the diseased state. In addition, a very recent study in cultured
human keratinocytes has reported that UVA irradiation in vitro
induced IL-12 mRNA and protein, but not IL-10 (Kondo and
Jimbow, 1998), observations which are consistent with a UVA-
dependent predominance of Th1 cytokines. The UVA-1 photo-
therapy of atopic dermatitis, however, has been shown to downreg-
ulate IFN-γ expression in the lesional skin (Grewe et al, 1994), and
has also been reported to upregulate IL-10 mRNA and protein in
normal human keratinocytes (Grewe et al, 1995). These mechanistic
data in human skin are contradictory to our present study, may
indicate important differences between human and murine skin,
or between in vivo and in vitro data, and need clarification.
The level at which UVA irradiation might upregulate IFN-γ
could involve other cytokines; it is also possible that the synergism
between IL-12 and the novel IL-18, which has been reported in
the regulation and induction of IFN-γ in T cells, macrophages,
and dendritic cells (Dinarello et al, 1998; Okamura et al, 1998)
may prove to be the ultimate target for UVA. The downstream
consequences of protective IFN-γ upregulation in mouse skin by
UVA radiation are also unknown but might involve other regulators
of T cell-mediated immune function such as adhesion molecules,
or additionally encompass the induction of any of numerous genes
transcribing proteins known to have photoprotective properties.
UVA induces gene expression by mechanisms different from UVB
or UVC (Grether-Beck et al, 1997), so that UVA-specific or
preferential products should be sought in future studies in order
to understand the phenomenon better. In summary, this study
demonstrating the photoimmunoprotective properties of UVA
radiation in a third experimental animal, the conventional haired
mouse, has confirmed that the phenomenon appears to act via the
inactivation of cis-urocanic acid, and has identified a dependence
of the mechanism upon IFN-γ.
We gratefully acknowledge the excellent animal husbandry of Chandrika
Abeywardana and John Fisher, and the University of Sydney Cancer Research
Fund for financial support for this study.
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